request an appointment online.
- Diagnosis & Treatment
- Care Centers & Clinics
- Lymphoma & Myeloma Center
As one of the few comprehensive programs in the country, MD Anderson’s Lymphoma and Myeloma Center is known for its groundbreaking treatments and leading diagnostic techniques. We continue to work every day to find new therapies for lymphomas and myelomas, a challenging and complex group of cancers.
The Lymphoma and Myeloma Center’s pathologists are specially trained to accurately diagnose and stage all types of lymphoma and myeloma, which is important for choosing the most effective treatment plan. Our diagnostic expertise covers rare lymphomas that most pathologists will never encounter.
For many lymphoma patients, their disease may be chronic. Personalized long-term care is especially important for patients who have relapsed. We provide monitoring and management programs so that cancer doesn’t rule your life.
The Lymphoma and Myeloma Center offers a range of innovative treatment options, including targeted therapies, vaccines and radio-immunotherapy, as well as clinical trials for new and relapsed disease.
Types of cancers we treat:
- Hodgkin lymphoma
- Non-Hodgkin lymphomas, including B-cell and T-cell lymphomas
- Mantle cell lymphoma
- Multiple myeloma
- Waldenström's macroglobulinemia
- Small cleaved-cell lymphoma
- Unusual or difficult cases
It was not the end of the world. There's so much hope out there, especially at MD Anderson.
The Lymphoma and Myeloma Center is located in the Main Building, Floor 6, near Elevator B.
Becoming Our Patient
Get information on patient appointments, insurance and billing, and directions to and around MD Anderson.
MD Anderson patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
The Lymphoma and Myeloma Center business hours are 8 a.m. to 5 p.m., Monday through Friday.
713-792-3510 (Current patients)
877-632-6789 (New patients)
Prevention & Screening
Many cancers can be prevented with lifestyle changes and regular screening.